Global Deglycyrrhetinic Acid Licorice Extract Market: Size, Share, and Growth Forecast to 2034

The global deglycyrrhetinic acid licorice extract (DGL) market was valued at US$18 million in 2023 and is projected to reach US$25 million by 2030, exhibiting a steady compound annual growth rate (CAGR) of 4.5% during the forecast period.

Deglycyrrhizic acid licorice extract, obtained through advanced processing to remove glycyrrhizin from the roots of Glycyrrhiza glabra, has evolved from a traditional herbal use to a scientifically validated ingredient in modern healthcare. Its unique properties—exhibiting mucosal protection, anti-inflammatory effects, and antioxidant capabilities—make it a versatile compound for use in digestive health products and other applications. Unlike standard licorice extracts, DGL eliminates concerns about high blood pressure and sodium retention by removing glycyrrhizin, positioning it as a safer alternative for long-term use across a diverse consumer base.

The complete report is available here:  https://www.24chemicalresearch.com/reports/261856/global-deglycyrrhizic-acid-licorice-extract-forecast-market-2024-2030-928

Market dynamics:

The trajectory of this market is shaped by a complex interaction of strong growth drivers, significant restraints being actively addressed, and emerging opportunities.

Strong market drivers that promote expansion

• Growing Consumer Preference for Naturally Derived Digestive Health Solutions:  The integration of DGL into digestive health supplements and functional foods is a major growth vector, driven by increasing consumer awareness of gut health. The global digestive health market, projected to exceed US$70 billion by 2027, reflects a growing consumer preference for evidence-based, natural ingredients. Clinical studies have shown that DGL-containing products can improve mild to moderate heartburn symptoms by 70–80%, making them an attractive alternative to traditional antacids. This effectiveness is driving adoption among consumers seeking preventative, long-term digestive health solutions rather than temporary symptom relief.

• Scientific Validation and Expanding Applications:  The nutraceuticals sector is experiencing significant growth through DGL's scientifically validated mechanism of action. Recent studies have demonstrated that DGL stimulates mucin production by 25–30% compared to a control group, enhancing the protective capacity of the gastric mucosal barrier. Furthermore, DGL's anti-inflammatory properties, shown in laboratory studies to reduce inflammatory markers by 40–50%, are expanding its applications to sports nutrition and joint health products. With the global nutraceuticals market exceeding US$500 billion, DGL is positioned as a key ingredient in the shift towards scientifically validated plant-based supplements.

• Adoption of DGL in the Pharmaceutical Industry for Gastrointestinal Disease Treatments:  The pharmaceutical industry is seeing increased adoption of DGL in evidence-based gastrointestinal disease treatments. When combined with conventional therapies, DGL has been demonstrated in clinical practice to accelerate ulcer healing rates by 15–20%. This synergistic effect is particularly valuable considering that approximately 8–10% of the world's population suffers from peptic ulcer disease. Pharmaceutical companies are leveraging these clinical benefits to develop formulations that enhance efficacy while maintaining a favorable safety profile, enabling them to command premium prices in a highly competitive market.

Download a free sample report:  https://www.24chemicalresearch.com/download-sample/261856/global-deglycyrrhizic-acid-licorice-extract-forecast-market-2024-2030-928

Key market restraints hindering recruitment

Despite its proven advantages, there are hurdles that must be overcome in order to achieve wider adoption in the market.

• Supply Chain Complexity and Quality Consistency:  The specialized extraction process required to produce high-quality DGL involves multiple purification stages and advanced equipment. This increases manufacturing costs by 25–35% compared to conventional plant extracts. Achieving a consistent bioactive compound profile remains challenging, with natural variations in the licorice root raw material affecting up to 20% of production batches. These quality control challenges pose a significant obstacle for manufacturers requiring standardized raw materials for pharmaceutical and nutraceutical applications where batch-to-batch consistency is critical.

• Regulatory Classification and Labelling Challenges:  DGL occupies a complex regulatory position between plant-derived supplements and pharmaceutical ingredients. In major markets such as the US and EU, extensive scientific documentation is required to navigate the regulatory pathway for structural/functional claims, and the approval process typically takes 12 to 24 months. Ongoing adaptations of regulations concerning traditional herbal medicines in Europe further complicate matters, as DGL must reconcile claims of traditional uses with the requirements of modern scientific evidence, potentially delaying the market introduction of innovative applications.

Key market challenges requiring innovation

Transitioning from standardized extracts to final products presents clear challenges. Maintaining component stability in various formulation matrices is difficult, and current encapsulation technologies achieve only 60–70% bioavailability in some delivery systems. Furthermore, ensuring masking effects in chewable and liquid formulations remains a problem, and DGL's distinctive flavor can compromise consumer acceptance in 30–40% of product concepts. These technical hurdles require significant R&D investment, often consuming 10–15% of raw material suppliers' revenues, thus creating a barrier for smaller market participants.
In addition, the market grapples with evolving agricultural practices and sustainability concerns. Climate change impacts licorice root quality and yield, with annual production fluctuating by 15–20% in major production regions. Growing attention to sustainable harvesting practices adds complexity to raw material sourcing, with certified sustainable licorice trading at 20–25% higher prices than conventional supplies, creating economic pressure across the entire value chain.

A huge market opportunity unfolds before us.

• Expansion into Functional Foods and Beverages:  DGL presents significant opportunities in the functional foods sector, particularly in digestive health products. Innovative applications in fortified beverages, functional confectionery, and health bars have demonstrated strong consumer acceptance, achieving repeat purchase rates of 40-50% in pilot products. With the global functional foods market projected to reach US$275 billion by 2025, DGL-fortified products, targeting digestive comfort, are poised to capture substantial market share, especially as consumers seek a holistic approach to gastrointestinal health.

• Development of Advanced Delivery Systems:  Innovative delivery technologies are creating new opportunities for DGL applications. Recent advances in targeted release formulations have shown an 80-90% improvement in the delivery of bioactive substances to specific gastrointestinal regions. The global advanced drug delivery systems market, valued at over US$200 billion, presents substantial potential for DGL incorporation. The development of mucosal adhesion technologies to extend gastric retention time opens up new possibilities for improved efficacy in gastrointestinal protective applications.

• Strategic Healthcare Professional Recommendations:  The market is increasingly integrating with professional healthcare recommendations. Currently, more than 35% of gastroenterologists recommend DGL supplements as a complementary approach, particularly for patients who wish to reduce their use of conventional medications. This professional endorsement is crucial in building consumer confidence and effectively increases market adoption by 25-30% in areas with strong healthcare professional networks. Educational initiatives in collaboration with manufacturers and healthcare professionals are essential for expanding evidence-based usage.

Detailed segment analysis: Where is the growth concentrated?

• By Type:
  The market is segmented into Pharmaceutical Grade, Food Grade, and Other Grades. Pharmaceutical Grade currently dominates the market due to its rigorous quality control, certified purity levels, and evidence-based suitability for healthcare applications. The Food Grade segment is essential for nutritional supplements and functional foods applications where a balance between high quality standards and cost considerations for consumer products is required.

• Application-Based Segments:
  Application segments include Food & Beverages, Nutraceuticals, Pharmaceuticals, and Other Applications. The Nutraceuticals segment currently holds the largest market share due to increasing consumer demand for preventative health solutions and digestive health products. However, the Pharmaceuticals segment is expected to exhibit the highest growth rate as more clinical evidence supports the therapeutic applications of DGL and regulatory pathways become clearer.

• End-User Industry Breakdown:
  The end-user landscape includes supplement manufacturers, pharmaceutical companies, and food and beverage manufacturers. Supplement manufacturers hold a major share, leveraging DGL's scientific profiles for digestive health products. The pharmaceutical and food sectors are rapidly emerging as important growth segments, reflecting trends toward integrated health solutions and functional food innovation.

Download a free sample report:  https://www.24chemicalresearch.com/download-sample/261856/global-deglycyrrhizic-acid-licorice-extract-forecast-market-2024-2030-928

Competitive landscape:

The global deglycyrrhetinic acid licorice extract market is moderately consolidated and characterized by competition focused on quality standards and scientific validation. Leading companies Jiangsu Tiansheng Pharmaceutical, Qinghai Lake Pharmaceutical, SA Herbal Bioactives, and Natural Remedies hold approximately 65% ​​of the market share as of 2023. Their dominance is supported by vertical integration from cultivation to extraction, advanced quality control systems, and established distribution networks in key markets.

List of major companies that were surveyed for their deglycyrrhizic acid licorice extract:

• Jiangsu Tiansheng Pharmaceutical (China)

• Qinghai Lake Pharmaceutical (China)

• SA Herbal Bioactives (India)

• Natural Remedies (India)

Competitive strategies primarily focus on quality improvement through advanced extraction techniques and scientific research to validate health claims. Companies are increasingly concentrating on forming partnerships with research institutions and end-users, developing application-specific solutions, and securing future market demand through evidence-based product development.

Regional Analysis: Global Development with Clear Leadership

• Asia Pacific:  This dominant region holds a 68% share of the global market. This leadership is driven by large-scale licorice cultivation in China and India, established practices in traditional medicine incorporating licorice, and strong manufacturing capabilities for plant extracts. China is a major production base and growth driver, supplying both domestic consumption and the global market.

• North America and Europe:  Together, these form the major secondary markets, accounting for 27% of global demand. North America's strengths are driven by high consumer awareness of digestive health supplements and a robust regulatory framework for dietary ingredients. The European market is characterized by sophisticated nutraceutical innovations and the expanding acceptance of herbal medicines through traditional use registration.

• Other regions:  These regions represent new opportunities for DGL market expansion. Although currently small in scale, they show significant growth potential due to increasing health awareness, expanding retail distribution of nutritional supplements, and the growing adoption of preventative healthcare approaches in developing countries.

The complete report is available here:  https://www.24chemicalresearch.com/reports/261856/global-deglycyrrhizic-acid-licorice-extract-forecast-market-2024-2030-928

Download a free sample report:  https://www.24chemicalresearch.com/download-sample/261856/global-deglycyrrhizic-acid-licorice-extract-forecast-market-2024-2030-928

About 24chemicalresearch

Founded in 2015, 24chemicalresearch has rapidly established itself as a leader in chemical market intelligence, serving more than 30 Fortune 500 clients. We deliver data-driven insights through a rigorous research methodology, addressing key industry drivers such as government policies, emerging technologies, and the competitive landscape.

• Plant-level production capacity tracking

• Real-time price monitoring

• Technological and economic feasibility study

International: +1(332) 2424 294 | Asia: +91 9169162030
Website: https://www.24chemicalresearch.com/